Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat dose-response in gout
NCT00174967Phase 2Completed
- Sponsor
- Takeda
- Start
- Jan 2001
- Primary completion
- Jul 2001
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of febuxostat in gout (4 arms), sponsored by Takeda. Primary endpoint: Percentage of Subjects Whose Serum Urate Level Decreased to <6.0 Milligram Per Deciliter (mg/dL) at Day 28. Started Jan 2001; status: completed.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT00174967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174967.